Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation

NCT02481154

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • UCLA Oncology Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma

NCT03529448

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain
  • Institut Català d'Oncología L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Mallorca, Spain
  • Hospital del Mar Barcelona, Spain
View Trial Details
Completed

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

NCT02909777

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, +22 more
Locations
  • University of California, San Francisco, Benioff Children's Hospital San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's, Baylor College of Medicine Houston, Texas, United States
View Trial Details

Related conditions